We've found
10,842 Neurology
clinical trials
We've found
10,842 Neurology
clinical trials
Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Oncology Clinical Trial
Updated: 12/31/1969
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Charcot Marie Tooth Disease Clinical Trial
Updated: 12/31/1969
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Dental / Maxillofacial Surgery, Neurology Clinical Trial
Updated: 12/31/1969
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Dental / Maxillofacial Surgery, Neurology Clinical Trial
Updated: 12/31/1969
Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Charcot Marie Tooth Disease Clinical Trial
Updated: 12/31/1969
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Charcot Marie Tooth Disease Clinical Trial
Updated: 12/31/1969
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Charcot Marie Tooth Disease Clinical Trial
Updated: 12/31/1969
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Progressive Multifocal Leukoencephalopathy Clinical Trial
Updated: 7/3/2014
Genetic Evaluation of Natalizumab-Treated Patients With Progressive Multifocal Leukoencephalopathy
Status: Enrolling
Updated: 7/3/2014
Click here to add this to my saved trials

Traumatic Brain Injury Clinical Trial
Updated: 12/31/1969
Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hereditary Hemorrhagic Telangiectasia Clinical Trial
Updated: 12/31/1969
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Hereditary Hemorrhagic Telangiectasia Clinical Trial
Updated: 12/31/1969
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Ischemic Stroke Clinical Trial
Updated: 2/19/2014
Assess the Penumbra System in the Treatment of Acute Stroke
Status: Enrolling,
Phase
IV
Updated: 2/19/2014
Click here to add this to my saved trials

Ischemic Stroke Clinical Trial
Updated: 2/19/2014
Assess the Penumbra System in the Treatment of Acute Stroke
Status: Enrolling,
Phase
IV
Updated: 2/19/2014
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Dermatology / Plastic Surgery, Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Musculoskeletal, Nephrology / Urology, Neurology, Ophthalmology, Otolaryngology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Other Clinical Trial
Updated: 4/2/2018
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Status: Enrolling,
Phase
Updated: 4/2/2018
Click here to add this to my saved trials

Hypoactive Sexual Desire Disorder Clinical Trial
Updated: 9/26/2011
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials

Hypoactive Sexual Desire Disorder Clinical Trial
Updated: 9/26/2011
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials

Hypoactive Sexual Desire Disorder Clinical Trial
Updated: 9/26/2011
Lybrido for Female Sexual Dysfunction
Status: Enrolling
Updated: 9/26/2011
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Sclerosis Clinical Trial
Updated: 12/31/1969
Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Reproductive Clinical Trial
Updated: 12/31/1969
Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology Clinical Trial
Updated: 12/31/1969
A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
